Documentos relacionados

1. The increase in bone mineral density by bisphosphonate with active vitamin D analog is associated with the serum calcium level within the reference interval in postmenopausal osteoporosis.
2. Does the use of bisphosphonates during pregnancy affect fetal outcomes? A systematic review.
3. [Effect of low doses of oral pamidronate (APD) on the calcemia of osteopenic or osteoporotic patients].
4. Continuation of Bisphosphonate Therapy for Osteoporosis beyond 5 Years.
5. Patterns of bisphosphonate treatment among patients with multiple myeloma treated at oncology clinics across the USA: observations from real-world data.
6. Comparative efficacy of sodium thiosulfate, bisphosphonates, and cinacalcet for the treatment of vascular calcification in patients with haemodialysis: a systematic review and network meta-analysis.
7. A randomized, open-label, controlled trial of monthly oral minodronate or semiannual subcutaneous injection of denosumab for bone loss by androgen deprivation in Asian men with prostate cancer: the PRevention of Osteopenia with Minodronate And DEnosumab (PROMADE) study.
8. Morphological and Morphometrical Analyses of Fracture-Healing Sites of an Atypical Femoral Fracture in Patients with and without Long-Term Bisphosphonate Treatment for Osteoporosis: A Report of Two Cases.
9. Comment on: Intravenous neridronate in the treatment of acute painful knee osteoarthritis: a randomized controlled study: reply.
10. Comment on: Intravenous neridronate in the treatment of acute painful knee osteoarthritis: a randomized controlled study.